Hashimoto, anti-TPO, and female hormones: why it is not all about TSH

Positive anti-TPO is not always Hashimoto.

This sentence sounds technical, but it changes the conversation a lot. Because thousands of women receive a lab result with elevated thyroid antibodies and leave with one of two opposite answers: "you have nothing" or "you already have Hashimoto". Both can be incomplete.

Hashimoto’s thyroiditis is not an isolated number. It is an autoimmune process where the immune system starts recognizing components of the thyroid as a threat. Sometimes it first appears as positive antibodies with normal TSH and T4. Sometimes it progresses to subclinical hypothyroidism. Sometimes it ends in overt hypothyroidism. And sometimes it stays for years as a silent signal.

The problem is that female health is rarely read this way: as a trajectory.

Four states that often get mixed together

In the public conversation, "high anti-TPO", "Hashimoto", and "hypothyroidism" are used as if they were the same thing. They are not.

There are at least four different states:

1. Isolated anti-TPO: positive antibodies, but normal TSH and free T4, with no clear signs of thyroid damage.
2. Euthyroid thyroid autoimmunity: positive antibodies, perhaps a compatible ultrasound, but still preserved hormonal function.
3. Subclinical Hashimoto: the thyroid still maintains free T4, but needs a higher TSH to sustain it.
4. Clinical Hashimoto: overt hypothyroidism is already present, with a clear loss of hormonal output.

The difference matters because not every woman in the first group needs the same conversation as a woman in the fourth. Anti-TPO can be a signal to monitor. Clinical Hashimoto is something else: a gland that has already lost part of its capacity.

The 2024 ASRM guideline and the TABLET and T4LIFE trials help ground this point: giving levothyroxine to euthyroid women with positive anti-TPO did not improve live births in those trials. That does not deny that autoimmunity matters. It says something more precise: isolated anti-TPO is not always a hormonal deficit that can be corrected with a single molecule.

The thyroid also talks to the ovary

The thyroid does not operate in isolation. Active thyroid hormone, T3, participates in reproductive tissues: granulosa, corpus luteum, and endometrium.

When tissue-level thyroid signaling drops, processes that matter for the cycle can be altered:

• Granulosa response to FSH.
• Estradiol production.
• Corpus luteum function.
• Luteal-phase progesterone.
• Endometrial receptivity.

That is why some women do not only have fatigue or feel cold. They also have spotting, shorter cycles, heavier bleeding, a weak luteal phase, or menstrual irregularity. Not because "the thyroid controls everything", but because the thyroid axis and reproductive axis share ground.

Here the central idea returns: TSH alone does not tell the whole story. It can say whether there is pressure on the thyroid, but it does not fully describe local signaling in the ovary, endometrium, metabolism, and inflammation.

Hashimoto can look like perimenopause

For Carmen, 47, this distinction is critical.

Perimenopause can bring insomnia, brain fog, irregular cycles, fatigue, hair loss, mood changes, and fat redistribution. Functional Hashimoto can also bring several of those symptoms. If a woman is in hormonal transition and also has early thyroid autoimmunity, the two processes overlap.

The clinical result is often a familiar phrase: "it’s age".

But it may not be only age. It may be a combination of an ovary in transition, more erratic luteal progesterone, fragmented sleep, disordered cortisol, low-grade inflammation, and variable thyroid signaling.

The useful question is not "is this perimenopause or thyroid?". Sometimes the right question is: which part of the pattern comes from each axis, and how does it change over time?

Iodine, microbiome, and immune tolerance

The most interesting finding from today’s Lua Labs report comes from Gong et al. 2024, published in Communications Biology.

The study connected three pieces that are often treated separately: iodine intake, gut microbiota, and Th17/Treg immune balance. In patients with Hashimoto, they found microbiota changes and lower serum butyrate. In animal models, excess iodine altered microbiota and metabolites, increased LPS, affected the intestinal barrier, reduced butyrate, and imbalanced Th17/Treg. When they gave butyrate, lymphocytic infiltration improved and part of the immune signal rebalanced.

Translated: iodine is not just "raw material for the thyroid". In excess, under certain contexts, it can increase antigenic and immune pressure. And the microbiome is not just "digestion". It can act as a buffer for immune tolerance.

This does not mean a woman should remove or add iodine on her own. It means the question is more nuanced: type of salt, dairy, bread, salty ultra-processed foods, seaweed, supplements, pregnancy, breastfeeding, family history, symptoms, and labs. In Latin America, where iodine exposure can come from cultural and processed sources that differ from those in the United States or Europe, that map matters.

PCOS and Hashimoto: a double entry

The overlap between PCOS and thyroid autoimmunity also does not seem accidental. A 2018 Romitti meta-analysis found higher odds of Hashimoto in women with PCOS.

The mechanistic reading makes sense. PCOS often brings insulin resistance, hyperandrogenism, low-grade inflammation, and anovulatory cycles. When ovulation is not consistent, luteal progesterone drops, and progesterone also participates in immune tolerance. If there is also autoimmune predisposition, extreme iodine exposure, an impoverished microbiome, or dysregulated cortisol, the system has more paths that can tilt it toward inflammation.

It is not "PCOS causes Hashimoto". It is more interesting: in some women, PCOS and Hashimoto may share an immuno-metabolic terrain.

For Valentina, 19, this matters because the conversation should not stop at "your cycles are irregular". We need to look at acne, cravings, energy, sleep, family history, thyroid symptoms, insulin, SHBG, TSH, free T4, free T3, anti-TPO, and anti-Tg. Not as a list for self-diagnosis, but as a map so signals are not missed.

The pattern Lua Labs proposes observing: HATF

Today, Lua Labs proposed a research biomarker: HATF, for Hashimoto Autoimmune Transition Fingerprint.

The idea is not to diagnose Hashimoto from an app. That would be incorrect. The idea is to study whether the transition from "isolated antibodies" to "functionally relevant Hashimoto" appears more clearly when several signals coincide:

• Sustained thyroid symptoms.
• Cycle-luteal irregularity.
• Extreme iodine exposure.
• Signals of insulin resistance or PCOS.
• Dysregulated sleep/cortisol.
• Family history or thyroid labs.
• Pattern of energy, cold sensitivity, constipation, hair loss, and brain fog.

Anti-TPO would be a seed. HATF tries to describe the ecosystem that decides whether that seed stays silent or becomes clinically relevant.

For now it is a research hypothesis, not a clinical tool. But it is exactly the kind of question a longitudinal hormonal intelligence app can learn to formulate better than a one-time questionnaire.

What to do with this as a user

Do not use this article to self-diagnose. Use it to ask better questions.

If you have persistent fatigue, cold sensitivity, constipation, hair loss, brain fog, irregular cycles, spotting, heavy bleeding, PCOS, family history of Hashimoto, or symptoms that worsen in perimenopause, it may be worth talking with your healthcare professional about a more complete thyroid evaluation.

The conversation may include TSH, free T4, free T3, anti-TPO, anti-Tg, ferritin, vitamin D, glucose/insulin, SHBG, and menstrual context. Not because everyone always needs every test, but because a single TSH can be too small a snapshot for a system that changes in layers.

Lua does not replace that consultation. What it can do is help you build the part that almost never exists: a longitudinal story of your symptoms, food, sleep, energy, and cycle.

Because your body does not speak in isolated labs. It speaks in patterns.

This article summarizes peer-reviewed scientific evidence for educational purposes. It does not replace individual medical evaluation, diagnosis, or treatment. If you identify with this pattern, consult a healthcare professional.